PubRank

Vicente Bertomeu

Author PubWeight™ 83.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007 20.09
2 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007 9.43
3 [An invasive strategy in non-ST-segment elevation acute coronary syndromes. From large trials to the real world]. Rev Esp Cardiol 2004 2.03
4 [Use of sirolimus-eluting stents in complex lesions: clinical and angiographic follow-up]. Rev Esp Cardiol 2004 1.60
5 Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists. Thromb Haemost 2015 1.49
6 [Emergency room risk stratification of patients with chest pain without ST segment elevation]. Rev Esp Cardiol 2003 1.46
7 [Treatment of acute myocardial infarction by primary angioplasty on-site compared with treatment following interhospital transfer: short- and long-time clinical outcomes]. Rev Esp Cardiol 2007 1.41
8 [Myocardial echocardiography with intracoronary injection of contrast in post-infarction patients. Implications and comparison with angiography and magnetic resonance imaging]. Rev Esp Cardiol 2004 1.40
9 Association between renal function and cardiovascular disease in patients with left ventricular hypertrophy. VIIDA study. J Clin Hypertens (Greenwich) 2009 1.40
10 [Sex differences in mortality at one-month and at one-year after an acute coronary syndrome]. Med Clin (Barc) 2004 1.39
11 [Plasma concentration of big endothelin-1 and its relation with plasma NT-proBNP and ventricular function in heart failure patients]. Rev Esp Cardiol 2005 1.38
12 Blood pressure control in hypertensive women aged 65 years or older in a primary care setting. MERICAP study. Rev Esp Cardiol 2011 1.38
13 Implantation of single-lead atrioventricular permanent pacemakers guided by electroanatomic navigation without the use of fluoroscopy. Europace 2008 1.30
14 Characteristics and outcome of acute myocardial infarction in young patients. The PRIAMHO II study. Cardiology 2006 1.13
15 Usefulness of an abnormal ankle-brachial index for detecting multivessel coronary disease in patients with acute coronary syndrome. Rev Esp Cardiol 2010 0.95
16 Obese subjects with heart failure have lower N-terminal pro-brain natriuretic peptide plasma levels irrespective of aetiology. Eur J Heart Fail 2005 0.91
17 [ESH/ESC 2007 Guidelines for the management of arterial hypertension]. Rev Esp Cardiol 2007 0.90
18 [Prognostic value of Charlson comorbidity index at 30 days and 1 year after acute myocardial infarction]. Rev Esp Cardiol 2004 0.90
19 Prognostic value of low ankle-brachial index in patients with hypertension and acute coronary syndromes. J Hypertens 2009 0.87
20 [Acute myocardial infarction in patients under 45 years]. Rev Esp Cardiol 2002 0.87
21 Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels. Am J Hypertens 2008 0.86
22 Prognostic usefulness of white blood cell count on admission and one-year outcome in patients with non-ST-segment elevation acute chest pain. Am J Cardiol 2006 0.86
23 Low lymphocyte count in acute phase of ST-segment elevation myocardial infarction predicts long-term recurrent myocardial infarction. Coron Artery Dis 2010 0.86
24 Variability of NT-proBNP plasma and urine levels in patients with stable heart failure: a 2-year follow-up study. Heart 2007 0.86
25 Usefulness of a comprehensive cardiovascular magnetic resonance imaging assessment for predicting recovery of left ventricular wall motion in the setting of myocardial stunning. J Am Coll Cardiol 2005 0.86
26 Impact of clinical and subclinical peripheral arterial disease in mid-term prognosis of patients with acute coronary syndrome. Am J Cardiol 2009 0.84
27 Combination of ankle brachial index and diabetes mellitus to predict cardiovascular events and mortality after an acute coronary syndrome. Int J Cardiol 2010 0.84
28 Complete regression of cardiac non-Hodgkin lymphoma. Int J Cardiol 2006 0.84
29 Variability of NT-proBNP and its relationship with inflammatory status in patients with stable essential hypertension: a 2-year follow-up study. PLoS One 2012 0.83
30 Diagnostic and prognostic value of urine NT-proBNP levels in heart failure patients. Eur J Heart Fail 2006 0.83
31 Inflammatory activation and left ventricular mass in essential hypertension. Am J Hypertens 2009 0.81
32 Prognostic significance of heart rate in hospitalized patients presenting with myocardial infarction. World J Cardiol 2012 0.81
33 Sex differences in the hypertensive population with chronic ischemic heart disease. J Clin Hypertens (Greenwich) 2008 0.80
34 Soluble TNF-alpha and interleukin-6 receptors in the urine of heart failure patients. Their clinical value and relationship with plasma levels. Eur J Heart Fail 2004 0.80
35 Usefulness of concomitant myoglobin and troponin elevation as a biochemical marker of mortality in non-ST-segment elevation acute coronary syndromes. Am J Cardiol 2003 0.80
36 Risk stratification in non-ST elevation acute coronary syndromes: predictive power of troponin I, C-reactive protein, fibrinogen and homocysteine. Int J Cardiol 2005 0.80
37 Plasma aldosterone and glomerular filtration in hypertensive patients with preserved renal function. Rev Esp Cardiol 2010 0.79
38 [Prognostic value of white blood cell count in acute myocardial infarction: long-term mortality]. Rev Esp Cardiol 2005 0.79
39 Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes. Am Heart J 2005 0.79
40 Impact of cardiovascular risk factors and inflammatory status on urinary 8-OHdG in essential hypertension. Am J Hypertens 2011 0.79
41 High heart rate: more than a risk factor. Lessons from a clinical practice survey. Int J Cardiol 2008 0.79
42 Prevalence of atrial fibrillation and use of antithrombotics in hypertensive patients aged >or=65 years. The FAPRES trial. Rev Esp Cardiol 2010 0.79
43 [Magnitude and characteristics of residual lipid risk in patients with a history of coronary revascularization: the ICP-bypass study]. Rev Esp Cardiol 2011 0.79
44 [NT-proBNP levels and hypertension. Their importance in the diagnosis of heart failure]. Rev Esp Cardiol 2004 0.78
45 Left ventricular cavity area reflects N-terminal pro-brain natriuretic peptide plasma levels in heart failure. Eur J Echocardiogr 2005 0.78
46 Prevalencia de fibrilación auricular y uso de fármacos antitrombóticos en el paciente hipertenso ≥ 65 años. El registro FAPRES. Rev Esp Cardiol 2010 0.78
47 [Interleukin-4 and cardiac fibrosis in patients with heart failure]. Rev Esp Cardiol 2007 0.78
48 [Prevalence of primary aldosteronism in hypertensive patients and its effect on the heart]. Rev Esp Cardiol 2008 0.77
49 [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study]. Rev Esp Cardiol 2007 0.77
50 [Influence of antecedent of hypertension in patients with acute coronary syndrome without ST elevation]. Med Clin (Barc) 2006 0.77
51 [Relationship between myocardial modelling and diastolic function in patients with essential hypertension]. Med Clin (Barc) 2011 0.77
52 Urinary B-type natriuretic peptide levels in the diagnosis and prognosis of heart failure. J Card Fail 2007 0.77
53 Usefulness of NT-proBNP level for diagnosing left ventricular hypertrophy in hypertensive patients. A cardiac magnetic resonance study. Rev Esp Cardiol 2008 0.76
54 Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice. J Hypertens 2008 0.76
55 Maximum longitudinal relaxation velocity of the left ventricle: its clinical value and relationship with NT-proBNP plasma levels in heart failure. Echocardiography 2006 0.76
56 [How beta-blockers are used in Spain? Analysis of limitations in their use in internal medicine and cardiology: CARACTER-BETA study]. Rev Esp Cardiol 2011 0.76
57 Ventricular hypertrophy increases NT-proBNP in subjects with and without hypertension. Int J Cardiol 2004 0.76
58 Impact of glomerular filtration rate on urinary BNP and NT-proBNP levels in heart failure. Peptides 2012 0.76
59 Metformin and risk of long-term mortality following an admission for acute heart failure. J Cardiovasc Med (Hagerstown) 2017 0.76
60 Cardiac incoordination induced by left bundle branch block: its relation with left ventricular systolic function in patients with and without cardiomyopathy. Cardiovasc Ultrasound 2008 0.75
61 Importance of perception for blood pressure control. Arch Intern Med 2008 0.75
62 [Hypertension in primary care. Are we aware of the magnitude of the problem and are we managing it properly?]. Rev Esp Cardiol 2005 0.75
63 [Atrio-ventricular block in Prinzmetal's angina refractary to medical treatment]. Med Clin (Barc) 2006 0.75
64 [Prognostic impact of anemia in acute heart failure]. Rev Invest Clin 2006 0.75
65 [8-hydroxy-2'-deoxyguanosine and lipid peroxidation in patients with heart failure]. Rev Esp Cardiol 2006 0.75
66 [Prognostic markers of non-ST elevation acute coronary syndromes]. Rev Esp Cardiol 2003 0.75
67 Urinary NT-proBNP. A valuable marker in the assessment of patients with essential hypertension. Rev Esp Cardiol 2009 0.75
68 Importance of recognizing occult renal disease in hypertensive patients. Rev Esp Cardiol 2009 0.75
69 [Independent role of C reactive protein to predict major events at one-month and at one-year in acute coronary syndrome without ST elevation]. Med Clin (Barc) 2004 0.75
70 Heart rate in acute heart failure, lower is not always better. Int J Cardiol 2010 0.75
71 [Usefulness of trimetazidine in ischemia-reperfusion lesion. Experimental study in myocardial stunning model]. Arch Cardiol Mex 2005 0.75
72 [Immunological alterations and selectin values in hypertensive patients treated according to current criteria]. Med Clin (Barc) 2010 0.75
73 [NT-proBNP and atrioventricular plane displacement. Relationship and diagnostic implications]. Rev Esp Cardiol 2003 0.75
74 [Introduction]. Rev Esp Cardiol (Engl Ed) 2012 0.75